Boston Scientific increased sales 5.6% in Q3 — 5 insights

Boston Scientific reported net sales of $2.22 billion in its third quarter fiscal year 2017 results.

Here's what you should know:

1. Boston Scientific's sales increased 5.6 percent year-over-year on a reported basis. .

2. Boston Scientific reported adjusted earnings of $283 million or $0.20 per share.

3. Boston Scientific CEO Mike Mahoney said in a release, "Our global team is delivering strong performance as we continue to invest in a deep and innovative portfolio and expand into faster-growing markets."

4. Boston Scientific's endoscopy division increased its sales by $7 million year-over-year.

5. Concerning rest-of-year outlooks, Boston Scientific expects earnings between $8.98 billion and $9.01 billion or a growth of up to 8 percent.

More articles on gastroenterology:
Gastro Health adds Dr. Robert Kaplan — 4 insights
GI center to know: Concord Endoscopy
CapsoVision earns CE Mark for CapsoCam Plus — 3 insights

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Top 40 Articles from the Past 6 Months